SEARCH RESULTS FOR: ("IOS免簽版(TG bot:搜wap2bot).xvs")(1094 results)

4.1mm Diameter, 4.8mm Platform TG Implant Length 10mm Sandblast Collar Height 2.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 14mm RBM Collar Height 1.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 12mm Sandblast Collar Height 1.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 12mm RBM Collar Height 1.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 10mm Sandblast Collar Height 1.8mm

4.1mm Diameter, 4.8mm Platform TG Implant Length 8mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 14mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 14mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 12mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 12mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 10mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 10mm RBM Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 8mm Sandblast Collar Height 1.8mm

3.3mm Diameter, 4.8mm Platform TG Implant Length 8mm RBM Collar Height 1.8mm

No Description

No Description

No Description

No Description

No Description

The ZEUS ELISA Thyroglobulin (Tg) IgG Test System is intended for the qualitative and semi-quantitative detection of IgG-class antibody to thyroglobulin in human serum. The test system is intended to be used as an aid in the diagnosis of thyroid diseases. This test is for In Vitro diagnostic use.

No Description

No Description

No Description

reSET-O® Mobile Application running on iOS. reSET-O is intended to increase retention of patients with opioid use disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic.

reSET® Mobile Application running on iOS. reSET is intended to provide cognitive behavioral therapy, as an adjunct to a contingency management system, for patients 18 years of age and older who are currently enrolled in outpatient treatment under the supervision of a clinician. reSET is indicated as a 12 week (90 days) prescription-only treatment for patients with substance use disorder (SUD), who are not currently on opioid replacement therapy, who do not abuse alcohol solely, or who do not abuse opioids as their primary substance of abuse. It is intended to: - increase abstinence from a patient’s substances of abuse during treatment, and - increase retention in the outpatient treatment program.

Stethee Pro Mobile iOS Application is a component of the Stethee Pro Software System. The Stethee Pro Software System is intended for use with the Stethee Pro Electronic Stethoscope.

Eversense 365 Mobile Application for iOS is a software application that runs on a mobile device (e.g., smart phone or tablet) and displays glucose data, trend information, and alerts.

Eversense CGM Mobile Application (iOS) is a software application that runs on a mobile device (e.g., smartphone or tablet) and displays glucose data, trend information, and alerts.

Eversense CGM Mobile Application (iOS) is a software application that runs on a mobile device (e.g., smartphone or tablet) and displays glucose data, trend information, and alerts.

Eversense CGM Mobile Application (iOS) is a software application that runs on a mobile device (e.g., smartphone or tablet) and displays glucose data, trend information, and alerts.